Brought online in phased commissioning since 2023, the East Plant represents a key milestone in our capacity expansion strategy.
Equipped with three state-of-the-art production workshops and one auxiliary facility, the plant focuses on high-value product lines including DFBP (core monomer for PEEK polymers), HAP (cosmetic raw materials), and 6Diol (cosmetic raw materials).
The East Plant has effectively addressed previous capacity constraints while upgrading overall operational standards. Advanced processes and precision equipment have driven tangible improvements in product consistency, production efficiency, and environmental performance, reinforcing our long-term commitment to reliable and sustainable manufacturing.

Operational since 2012, the West Plant has delivered over a decade of stable, high-performance production.
With an annual capacity of 4,200 metric tons, the facility produces a diversified portfolio including benzophenone derivatives, acetophenone derivatives, and dozens of aromatic ketone derivatives.
As a mature manufacturing base for core product lines, the West Plant reliably serves global markets with high-performance polymer monomers, photoinitiators, and other critical intermediates—supported by a well-established operational system that ensures consistent quality, supply reliability, and scalable production.